Not only do kidney disease patients have higher rates of cardiovascular events, cardiovascular disease events may increase the risk of end-stage renal disease in the general population.
The presence of hyperlipidemia following hospitalization for acute myocardial infarction or acute decompensated heart failure may be associated with reduced mortality.
Although widely used risk scores provide insight into the prognosis of patients with heart failure, they should be improved to take into account sex- and group-specific disease phenotypes and etiologies.
Among patients with asthma and chronic obstructive pulmonary disease overlap, long-acting beta2-agonist therapy is associated with a decreased risk for myocardial infarction.
Hypertrophic cardiomyopathy in black vs white patients may be associated with a greater burden of functional heart failure and reduced access to care and genetic testing.
